Ophthalmic manifestations of paranasal sinus disease: a clinical grading system.

Autor: Al Anazy FH; Ear, Nose, and Throat (ENT) Department, King Saud University Medical College, Riyadh, Saudi Arabia. waelamro@hotmail.com, Al Dousary SH
Jazyk: angličtina
Zdroj: International forum of allergy & rhinology [Int Forum Allergy Rhinol] 2012 Jul-Aug; Vol. 2 (4), pp. 331-5. Date of Electronic Publication: 2012 Mar 12.
DOI: 10.1002/alr.21029
Abstrakt: Background: Ophthalmic complications are common manifestations of paranasal sinus disease. We propose a clinical grading system to standardize the category, treatment, and outcome of these complications.
Methods: Forty-two patients with paranasal sinus disease-induced ophthalmic complications were included in the study. The patients were categorized according to their clinical presentation: Grade I, patients with anatomical disturbance; Grade II, patients with ophthalmic functional involvement; Grade III, patients with orbital infection; and Grade IV, patients with visual impairment.
Results: The age of the patients ranged from 8 to 65 years (mean = 30 years). Overall, 36% patients had ophthalmologic manifestations with anatomical disturbance (Grade I), 26% had functional disturbance (Grade II), 26% had orbital infections (Grade III), and 12% had visual loss (Grade IV). The cause of the ophthalmic manifestations was allergic fungal sinusitis in 50%, chronic rhinosinusitis in 36%, acute sinusitis in 10%, and mucocele in 4%. The most common ophthalmic manifestation was proptosis (36%), followed by orbital infection (26%), functional involvement (26%), and visual impairment (12%). The patients underwent functional endoscopic sinus surgery and medical treatment when indicated. The outcome in Grades I, II, and III was favorable; the outcome in Grade IV was not favorable.
Conclusion: This simple clinical grading system provides a useful tool for assessing the overall status of ophthalmic complications of Acute and chronic paranasal sinus disease at the initial clinical assessment and for subsequent management of these complications.
(Copyright © 2012 American Rhinologic Society-American Academy of Otolaryngic Allergy, LLC.)
Databáze: MEDLINE
Externí odkaz: